Skip to main content

This Week in PLoS: Mar 5, 2012

In PLoS Biology this week, investigators at MD Anderson Cancer Center and their collaborators show that "p53 plays an active role in promoting differentiation of human embryonic stem cells and opposing self-renewal by regulation of specific target genes and microRNAs." Further, the team writes, "p53 activates expression of miR-34a and miR-145, which in turn repress stem cell factors OCT4, KLF4, LIN28A, and SOX2 and prevent backsliding to pluripotency." and This study "underscores the importance of a p53-regulated network in determining the human stem cell state," the authors add.

In PLoS Genetics this week, a team led by researchers at Harvard Medical School presents its genomic characterization of the filamentous fungal endophyte Ascocoryne sarcoides. "This is one of the highest quality fungal genomes and, to our knowledge, the only thoroughly annotated and transcriptionally profiled fungal endophyte genome currently available," the authors write. "The analyses and datasets contribute to the study of cellulose degradation and biofuel production and provide the genomic foundation for the study of a model endophyte system."

Also in PLoS Genetics, University of California, San Diego's Jason Chan and Richard Kolodner show that multiplex ligation-dependent probe smplification "is a versatile technique for the rapid analysis of GCRs [gross chromosomal rearrangements] and can facilitate the genetic analysis of the pathways that prevent and promote GCRs and aneuploidy."

And in PLoS One this week, investigators at the Wellcome Trust Centre for Human Genetics and elsewhere show that "genomic regions associated with multiple sclerosis are active in B cells," and add that analyses like theirs "in other immunological cell types relevant to MS and functional studies are necessary to fully elucidate how genes contribute to MS pathogenesis."

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.